C-MER MEDICAL (03309) repurchased 240,000 shares for HK$189,900 on September 24.
C-MER Medical (03309) announced that on September 24, 2026, the company repurchased 240,000 shares for HK$189,900, at a repurchase price of HK$0.78-0.8 per share.
C-MER MEDICAL (03309) announced that on September 24, 2026, the company repurchased 240,000 shares for HK$189,900, at a repurchase price of HK$0.78-0.8 per share.
Related Articles
EDDING GENOR (06998) repurchased 2 million shares for HK$3.3987 million on September 24.
UNITED LAB (03933): Marketing registration application for insulin degludec and liraglutide injection accepted
Beijing Sanyuan Foods (600429.SH) plans to launch the second phase of its restricted stock incentive plan.
EDDING GENOR (06998) repurchased 2 million shares for HK$3.3987 million on September 24.
UNITED LAB (03933): Marketing registration application for insulin degludec and liraglutide injection accepted
Beijing Sanyuan Foods (600429.SH) plans to launch the second phase of its restricted stock incentive plan.
